Sandostatin LAR depot 10 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26FM41P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,579
Award facts
- Contract value 100% obligated
- $22,578.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,578.67 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 16, 2026, for the supply of Sandostatin LAR Depot 10 mg kits, with a completion date of January 20, 2026. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. The parent company Cencora, Inc. holds this significant $999.99 million IDC with DLA Troop Support Medical, enabling the delivery of a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The delivery of Sandostatin LAR Depot 10 mg, an acromegaly and neuroendocrine tumor treatment, exemplifies the company's role in supplying specialized pharmaceutical commodities to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FM41P?
SPE2DR26FM41P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FM41P worth?
The government has obligated $22,579 on SPE2DR26FM41P.
Is contract SPE2DR26FM41P an order under another contract?
Yes. SPE2DR26FM41P is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM41P competed?
The extent of competition for SPE2DR26FM41P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award